HCP Connect Contributor
Dr. Vikram Patel
Dr. Vikram Patel contributes neurology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.
Recent Drug Updates
35 total
Neurology
FDA Approves Efgartigimod for Myasthenia Gravis: New Treatment Algorithm for AChR Negative MuSK Negative Patients
Efgartigimod approved for myasthenia gravis: new treatment algorithm for AChR negative MuSK negative patients.
Neurology
FDA Extends PDUFA for Lecanemab Autoinjector: Weekly Home Administration for Alzheimer’s
FDA extends PDUFA for lecanemab: weekly home administration for Alzheimer’s disease treatment.
Neurology
FDA Approves Efgartigimod for Myasthenia Gravis: New Treatment Algorithm for Seropositive and Seronegative Patients
Efgartigimod approved for myasthenia gravis: new treatment algorithm for seropositive and seronegative patients.
Neurology
FDA Approves Lecanemab for Alzheimer: Coverage Criteria and MACE Monitoring
FDA approves lecanemab for Alzheimer: coverage criteria include amyloid PET scan and MACE monitoring.
Neurology
FDA Approves Efgartigimod for Myasthenia Gravis: Treatment Algorithm for AChR Negative Patients
Efgartigimod approved for seronegative myasthenia gravis: new treatment algorithm for AChR negative patients.
Neurology
FDA Approves Glatiramer Acetate Biosimilar for Relapsing MS: First Complex Injectable Generic
FDA approves glatiramer acetate biosimilar for relapsing MS, enhancing treatment access and affordability.
Neurology
FDA Approves Donanemab for Alzheimer: Subcutaneous Dosing Options Available
FDA approves donanemab for Alzheimer: 27% cognitive decline reduction with new subcutaneous dosing option.
Neurology
FDA Approves Lecanemab for Alzheimer: Biweekly IV vs Weekly SC Dosing
FDA approves lecanemab for Alzheimer: biweekly IV vs weekly SC dosing for better patient adherence.
Neurology
FDA Approves Wellcovorin for Cerebral Folate Transport Deficiency: First-Ever Treatment
FDA approves Wellcovorin for cerebral folate transport deficiency, the first-ever treatment for this rare condition.
Neurology
FDA Approves Ofatumumab and Natalizumab: High Efficacy Options for MS Management
FDA approves ofatumumab and natalizumab for MS: high-efficacy options reduce relapse rates and improve patient outcomes.
Neurology
FDA Approves Lecanemab for Alzheimer: Patient Selection Criteria and Amyloid PET Eligibility
FDA approves lecanemab for Alzheimer: patient selection and amyloid PET eligibility criteria critical for treatment.
Neurology
FDA Approves Donanemab for Alzheimer’s Disease: Amyloid Plaque Reduction in TRAILBLAZER-ALZ 2 Trial
FDA approves donanemab for Alzheimer’s disease: significant amyloid plaque reduction in TRAILBLAZER-ALZ 2 trial.
Neurology
FDA Approves Wellcovorin for Cerebral Folate Transport Deficiency: First Treatment Available
FDA approves Wellcovorin for cerebral folate transport deficiency, the first treatment for this rare condition, improving patient outcomes.
Neurology
FDA Approves Lecanemab for Alzheimer: Weekly Dosing to Enhance Treatment Adherence
FDA approves lecanemab for Alzheimer’s disease: 27% cognitive decline reduction with weekly dosing.
Neurology
FDA Approves Ofatumumab and Natalizumab for High Efficacy in Multiple Sclerosis Treatment
FDA approves ofatumumab and natalizumab for multiple sclerosis: high-efficacy options for patients with relapsing forms.
Neurology
FDA Approves Copper Histidinate for Menkes Disease: 78% Survival Benefit in Pediatric Patients
FDA approves Zycubo for Menkes disease: 78% survival benefit in pediatric patients.
Gene Therapy
CRISPR Gene Therapy: A New Frontier in Sickle Cell Disease Treatment
Explore the latest advances in CRISPR gene therapy for sickle cell disease and its potential for curative treatment.
Neurology
Improve Parkinson's Symptoms with Targeted Therapy
Discover how optimized speech and movement therapy can improve motor and nonmotor symptoms in Parkinson's disease patients, enhancing overall quality of life.
Medical Devices
Streamline Molecular Testing with Integrated Solutions
Discover how a strategic partnership can simplify workflow and improve biospecimen storage for Contract Research Organizations and pharmaceutical partners.
Neurology
New Target to Reduce MS Inflammation
Discover how mesenchymal stem cells in secondary progressive multiple sclerosis drive proinflammatory T-cell activity and potential therapeutic targets to reduce inflammation in MS...
Neurology
Identify Macromastia to Reduce Headache Risk
Learn how recognizing macromastia in women can help reduce headache risk and improve patient outcomes with referral options and conservative treatments.
Medical Research
Reduce PPIX Accumulation by 30% with GlyT1 Inhibition
Discover how blocking extracellular glycine uptake mitigates protoporphyria, reducing protoporphyrin IX accumulation in erythrocytes and plasma tissues by inhibiting GlyT1.
Medical Research
Boost Transplant Success with Novel Immunosuppression
Discover how costimulation blockade promotes tolerance, reducing rejection in cardiac transplantation and improving patient outcomes with alternative therapies.
Medical Research
New Compound Induces Lytic Cell Death in Tumor Models
Discover how a novel compound triggers pyroptosis, offering a potential therapeutic approach to overcome melanoma's resistance to apoptosis and activate antitumoral immunity.
Medical Research
TBX3 Mutations Linked to Hepatic Clonal Expansion
Discover how somatic mutations in TBX3 impact liver disease, including hepatic clonal expansion and VLDL secretion, with implications for clinical practice.
Health News
Mental Health Screenings in Schools: What's at Stake for Patients
Experts weigh in on proposed changes to mental health screenings in schools, citing potential consequences for early intervention and treatment outcomes.
Medical Research
Long COVID's Impact on Menstrual Cycles
Research explores the bidirectional relationship between long COVID and menstruation, shedding light on menstrual disturbances in women with long-term COVID-19 symptoms.
Medical Research
Identify Aggressive Breast Cancer Sooner
New lymph node study reveals how breast cancer evades immune detection, informing treatment choices and survival chances for patients.
Neurology
New Treatment Lowers Heart Attack and Stroke Risk
Learn about a new medication that can help reduce the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes.
Medical Research
Unlock Tomatillo Benefits
Discover the taste and health benefits of tomatillos, a nutrient-rich food that's easy to add to your diet for a healthier you.
Wellness
Identify Hidden Heart Attack Signs
Learn to distinguish between heartburn and potential heart attack symptoms to improve patient outcomes and save lives.
Neurology
Empower Your Neurology Career
Learn how to overcome challenges and advance your neurology career with expert-led sessions and networking opportunities at the Women in Neurology Conference.
Neurology
Empower Your Neurology Career with Community Support
Connect with fellow women neurologists, enhance your skills, and relax at a weekend conference designed for professional and personal growth.
Neurology
Reduce Dyskinesia with Continuous Infusion Therapy
Discover how continuous infusion therapies can provide stable symptom control and reduce "off" time for Parkinson's disease patients experiencing motor fluctuations.
Digital Health
AI Automates 30% of Patient Calls
Discover how conversational AI can reduce administrative burdens and improve patient experience, freeing up more time for healthcare professionals to focus on care.